Tumor expression of miR-210 significantly increased in LC-COPD compared to LC patients, while that of its downstream targets FGFRL-1 and EFNA-3 was reduced in the former patients (Fig. 2a and Table 2). This evidence concerns the gene EFNA3 and chronic obstructive pulmonary disease.